The UK prediabetes market is a representation of a mature and dynamically developing healthcare environment, which is driven by the increasing incidence of metabolic disorders, the high priority placed on early diagnosis and prevention, and the adoption of lifestyle management approaches, digital health solutions, and pharmacological therapies.